Osteoinductive bone graft substitutes.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 10766068.
- Also identified by PMC identifier 3611431.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This review will summarize the major efforts currently underway to develop osteoinductive bone graft substitutes for minimally invasive spine fusions. The primary categories of substitute include purified bone growth factors, recombinant bone growth factors, and growth factors delivered by gene therapy approaches. Clinical trials are underway for the purified and recombinant bone growth factors and pre-clinical studies have yielded promising results for a variety of gene therapy techniques for generating bone.
Medical subject headings
- Bone Substitutes
- Osseointegration